Fulminant acute hepatitis b after infliximab in Crohn’s disease

Authors

  • Olfa Hellara
  • Aroua Gueddiche
  • Aya Hammami
  • Wissem Melki
  • Wafa Ben Mansour
  • Hichem Loghmari
  • Nabil Ben Chaabène
  • Fethia BDIOUI
  • Leila Safer
  • Hammouda Saffar

Downloads

Download data is not yet available.

References

Gunda Millonig, Michaela Kern, Othmar Ludwig, Karin Nachbaur, Wolfgang Vogel. Subfulimanant hepatitis B after infliximab in crohn's disease: Need for HBV-screening? World J Gastroenterol 2006;12:974-6.

Pérez Alvarez R, Diaz Lagares C, Garcia Hermà ndez F, Lopez-Roses L, Brito- Zron P, Pérez-de-Lis M et al. Hepatitis B virus réactivation receiving in patints receiving tumor necrosis factor -targeted therapy: anlysis of 257 cases.Medecine 2011;6:359-71.

Debbie M Nathan, Peter W Angus and Peter R Gibson. Hepatitis B and C virus infections and anti-tumor necrosis factor-α therapy: Guidelines for clinical approach. Journal of Gastroenterology and Hepatology 2006;21:1366-71.

Downloads

Published

2014-09-16

Issue

Vol. 92 No. 5 (2014): Issue May 2014

Section

brief case reports